NCT06550466

Brief Summary

Osteoporosis is a major contributor to loss of independence due to bone fractures and resulting hospital treatments lead to significant morbidity. While pharmacological treatments can reduce consequences of osteoporosis, there is a pressing need for non-pharmacological interventions to improve bone health across the life-course and to reduce likelihood of age-related bone disease. This study will allow us to determine whether synergistic potentiating effects on bone metabolism are observed in humans in relation to the timing of food ingestion and what recommendations can be made to people with respect to food ingestion and exercise to obtain the maximal bone benefits from aerobic exercise. Furthermore, if we can identify interventions that potentiate bone's response to aerobic exercise in younger adults, then such interventions may have the ability to maximise bone mass in younger adults so that with ageing, the additional bone mineral density and improved bone microarchitecture would extend the time before osteoporotic "fracture thresholds" are reached. Therefore, understanding the bone metabolic response to exercise following fasting and feeding in younger adults is important.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 13, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

August 13, 2024

Status Verified

August 1, 2024

Enrollment Period

5 months

First QC Date

July 30, 2024

Last Update Submit

August 8, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • C-terminal telopeptide of type-1 collagen (CTX-1)

    The primary endpoint of this study is the change of the bone resorption biomarker C-terminal telopeptide of type-1 collagen (CTX-1) expression

    Between pre-exercise and 2 hours following the exercise timepoints

Secondary Outcomes (4)

  • Procollagen type 1 N-terminal propeptide (P1NP)

    Between pre-exercise and 2 hours following the exercise timepoints

  • Cortisol

    Between pre-exercise and 2 hours following the exercise timepoints

  • Insulin

    Between pre-exercise and 2 hours following the exercise timepoints

  • Glucose

    Between pre-exercise and 2 hours following the exercise timepoints

Study Arms (3)

Breakfast only

EXPERIMENTAL

Breakfast only without the exercise protocol

Other: Breakfast only

FAST

EXPERIMENTAL

Participants will be exercised 90 minutes following a 12-hour overnight fast

Other: FAST

FED

EXPERIMENTAL

Participants will be exercised 90 minutes after a meal

Other: FED

Interventions

Participants will attend a breakfast-only arm without the exercise protocol.

Breakfast only
FASTOTHER

Participants will be exercised for 90 minutes following a 12-hour overnight fast

FAST
FEDOTHER

Participants will be exercised 90 minutes after a breakfast

FED

Eligibility Criteria

Age24 Years - 32 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male (females excluded to remove the interplay between menstrual cycle and bone turnover)
  • Caucasian ethnicity
  • Aged 28 ± 4 years
  • Are physically active (meet the UK guidelines for physical activity of at least 150 minutes moderate intensity activity and/or at least 75 minutes of vigorous intensity activity per week)
  • Otherwise, healthy, able and willing to participate and provide written informed consent

You may not qualify if:

  • Current smokers
  • Excessive alcohol consumption (max 15 alcohol units/week)
  • Any musculoskeletal injury/disabilities
  • Any conditions known to affect bone metabolism (e.g. uncontrolled hyper-/hypothyroidism, hyperparathyroidism, hypo-/hypercalcaemia) or malabsorption syndromes (e.g. Crohn's disease, coeliac disease or inflammatory bowel disease).
  • Taking any medication known to affect bone metabolism (such as glucocorticoids or bisphosphonates)
  • Positive Covid-19 test within the last 8 weeks
  • Suffered a fracture in the previous 12 months
  • Have been told by medical professionals that they should not take part in moderate to high intensity exercise
  • Should not be a professional athlete or take part in significant competitive recreational activity (takes no more than 4 structured exercise sessions per week on average)
  • History of diagnosed eating disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Bone Diseases, MetabolicOsteoporosis

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Central Study Contacts

Simon Bowles, PhD

CONTACT

Jasmine Samvelyan, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: In this three-arm randomised crossover study, sixteen young adult men (age: 28 ± 4) will be recruited in good physical condition. Participants will be exercised following a 12-hour overnight fast (FAST) and exercised 90 minutes after a meal (FED) to test the temporal sensitivity of the loaded bone to absorbed nutrients. Participants will also attend a breakfast-only arm (without the exercise protocol). Participants will undergo a baseline assessment for health history (PAR-Q). The blood samples will be collected (10ml) and osteogenic response to exercise will be determined by measuring markers of bone formation; P1NP and resorption; CTX-1 and cortisol; marker of physiological and psychological stress. Insulin and glucose measurements will allow to assess the change of concentrations in fasted and fed states.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2024

First Posted

August 13, 2024

Study Start

October 1, 2024

Primary Completion

March 1, 2025

Study Completion

June 1, 2025

Last Updated

August 13, 2024

Record last verified: 2024-08